Taiho Pharmaceutical's press releases may contain information about prescription drugs including products currently under development, however information contained in the press releases are not intended to constitute promotion, advertisement, or medical advice.
2008
-
October 01, 2008
Basic agreement reached with Nippon Shinyaku for the collaborative development and marketing of a new antipruritic agent (code NS-141)
-
October 01, 2008
Domestic manufacture of downsized Uzel (calcium folinate) 25 mg tablets to be started soon
-
October 01, 2008
Autumn 2008 version TV commercial for Tiovita Drink is aired
-
September 30, 2008
Zosyn, a new injectable combination antibiotic of beta-lactamase inhibitor and penicillin domestically launched on October 1
-
September 30, 2008
Taiho Pharmaceutical collaborates with and supports the Japan Pink Ribbon Campaign for this year
-
September 29, 2008
46th fiscal-year (07/2007- 06/2008) report is released
-
September 22, 2008
New website contents to promote medical check-ups for breast cancer are released
-
September 02, 2008
The antipsoriatic ethical drugs, Urepearl-Plus Lotion 10 and Urepearl-Plus Cream are launched on September 3
-
August 20, 2008
8th Oncology Media Seminar is held: Main topic - Current therapyfor breast cancer
-
July 25, 2008
Notice: Three Otsuka group companies (Otsuka Pharmaceutical Factory, Otsuka Warehouse, and Taiho Pharmaceutical) are reorganized as wholly-owned direct subsidiaries
-
July 18, 2008
License agreement with Sanofi-Aventis on TS-1 is terminated
-
July 18, 2008
Results of a randomized comparative phase 3 study of
S-1 in advanced/recurrent gastric cancer become available
-
July 16, 2008
Notice: Acquisition of production/distribution license for Zosyn, a new injectable combination antibiotic of beta-lactamase inhibitor and penicillin
-
June 24, 2008
Summer 2008 version TV commercial for Tiovita Drink is aired
-
April 07, 2008
7th Oncology Media Seminar is opened: Main topic - Gastric cancer: Clinical studies of oral anti-gastric cancer agents and guidelines for the treatment of gastric cancer
-
March 25, 2008
Results of a randomized comparative study of S-1 monotherapy compared to S-1 with cisplatin (SPIRITS trial) in advanced/recurrent gastric cancer is published in Lancet Oncology: New standard therapy for advanced gastric cancer anticipated
-
January 18, 2008
Spring 2008 version TV commercial for Tiovita Drink is aired
